Diabetes and Myocardial Fibrosis: A Systematic Review and Meta-Analysis.

Salvador, Dante B. Jr.; Gamba, Magda R; Gonzalez Jaramillo, Nathalia; Gonzalez-Jaramillo, Valentina; Raguindin, Peter Francis N; Minder, Beatrice; Gräni, Christoph; Wilhelm, Matthias; Stettler, Christoph; Doria, Alessandro; Franco, Oscar H; Muka, Taulant; Bano, Arjola (2022). Diabetes and Myocardial Fibrosis: A Systematic Review and Meta-Analysis. JACC. Cardiovascular imaging, 15(5), pp. 796-808. Elsevier 10.1016/j.jcmg.2021.12.008

Preview	Text Salvador_JACCCardiovascImaging_AAM.pdf - Accepted Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (3MB) | Preview
Preview	Text Salvador-JIMG081621-1279DR_Supplemental.pdf - Supplemental Material Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (2MB) | Preview
	Text Salvador_JACCCardiovascImaging_2022.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (1MB) | Request a copy

Objectives

This systematic review and meta-analysis investigated the association of diabetes and glycemic control with myocardial fibrosis (MF).
Background

MF is associated with an increased risk of heart failure, coronary artery disease, arrhythmias, and death. Diabetes may influence the development of MF, but evidence is inconsistent.
Methods

We searched EMBASE, Medline Ovid, Cochrane CENTRAL, Web of Science, and Google Scholar for observational and interventional studies investigating the association of diabetes, glycemic control, and antidiabetic medication with MF assessed by histology and cardiac magnetic resonance (ie, extracellular volume fraction [ECV%] and T1 time).
Results

A total of 32 studies (88% exclusively on type 2 diabetes) involving 5,053 participants were included in the systematic review. Meta-analyses showed that diabetes was associated with a higher degree of MF assessed by histological collagen volume fraction (n = 6 studies; mean difference: 5.80; 95% CI: 2.00-9.59) and ECV% (n = 13 studies; mean difference: 2.09; 95% CI: 0.92-3.27), but not by native or postcontrast T1 time. Higher glycosylated hemoglobin levels were associated with higher degrees of MF.
Conclusions

Diabetes is associated with higher degree of MF assessed by histology and ECV% but not by T1 time. In patients with diabetes, worse glycemic control was associated with higher MF degrees. These findings mostly apply to type 2 diabetes and warrant further investigation into whether these associations are causal and which medications could attenuate MF in patients with diabetes.

Interest & Impact

Downloads

43 since deposited on 09 Mar 2022
38 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item